Line 471: | Line 471: | ||
Our best composite part is ACTB:CD4-ComD-mKO2, which consists of our CD4-ComD-mKO2 construct driven by the constitutive ACTB promoter. | Our best composite part is ACTB:CD4-ComD-mKO2, which consists of our CD4-ComD-mKO2 construct driven by the constitutive ACTB promoter. | ||
</div> | </div> | ||
− | <div class="p" style="position: absolute; top: | + | <div class="p" style="position: absolute; top: 14vw; left: 2vw; margin-right: 4vw;"> |
Please use the links below to learn more about our Composite parts! | Please use the links below to learn more about our Composite parts! | ||
</div> | </div> | ||
Line 478: | Line 478: | ||
<tr> | <tr> | ||
<th>Name</th> | <th>Name</th> | ||
− | |||
<th>Description</th> | <th>Description</th> | ||
</tr> | </tr> |
Revision as of 16:17, 16 October 2018
Composite Parts
Our best composite part is ACTB:CD4-ComD-mKO2, which consists of our CD4-ComD-mKO2 construct driven by the constitutive ACTB promoter.
Please use the links below to learn more about our Composite parts!
Name | Description |
---|---|
BBa_K2649016 | ActB: comD UA159 |
BBa_K2649012 | Hef1a : eComE |
BBa_K2649017 | Hef1a:iRFP |
BBa_K2649015 | hEF1a: ComE NN2025 |